These success, along with a earlier report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the concept of targeting ACKR3 as a unique strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-related disorders. Submitting this overview ensures that https://johni727wyc7.blogginaway.com/profile